Triple-negative breast cancer (TNBC) refers to a form of breast malignancy that is negative for the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor 2 (HER2), accounting for 10–15% of human breast cancers [1,2]. The gene discussed is PGR; the disease is triple-negative breast carcinoma.